Efficacy and Safety of Sofosbuvir and Ribavirin in Treatment of Chronic Hepatitis C Infection G3 of Multi-Transfused Children Aged 4 To 12 Years; A Single Center Study . mfm [Internet]. 2023 Jul. 30 [cited 2025 Dec. 27];34(7). Available from: https://medicalforummonthly.com/index.php/mfm/article/view/4409